Navigation Links
Avandia Heart Risks Buried by Drug Company: Report
Date:7/13/2010

equest. The results, announced in June of 2009, found that Avandia raised the risk of heart failure but not to a level of statistical significance. The study also concluded that the drug did not increase the risk of cardiovascular disease or overall death.

In his posting, Thomas A. Marciniak, medical team leader of the division of cardiovascular and renal products at the FDA's Center for Drug Control and Evaluation, said that "RECORD was inadequately designed and conducted to provide any reassurance about the [cardiovascular] safety of rosiglitazone" and that "RECORD suggests the (sic) rosiglitazone increases the risk for [heart attacks]."

Last June, Glaxo used the trial results to tout the drug's safety.

"RECORD provides important and reassuring information about Avandia for physicians fighting diabetes," said Dr. Ellen Strahlman, Glaxo's chief medical officer, in a statement released at the time. "We believe that the results showed that Avandia is safe."

On Friday, the company, in a prepared statement, said, "The RECORD study was conducted according to good clinical practices and the data are reliable. . . RECORD demonstrated that Avandia was not associated with an overall increase in cardiovascular hospitalization or cardiovascular death compared to metformin and sulfonylureas."

But Dr. Kirk Garratt, clinical director of interventional cardiovascular research at Lenox Hill Hospital in New York City, said Friday, "If the data from RECORD had truly been mishandled in some way, not only is it going to pretty well be the end of Avandia in the clinical world, but it's going to put GlaxoSmithKline under the magnifying glass in an important way for clinicians going forward. They'll lose credibility, and that's tough to get back."

"There is an alternative drug out there," Garratt added. "From the clinical side, it's a fortunate circumstance that we find ourselves in, since we have an alternative product that seems to have [litt
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Diabetes Drugs Avandia, Actos Tied to Fractures in Women
2. Remove Diabetes Drug Avandia From Market: FDA Reports
3. Remove Diabetes Drug Avandia From Market: FDA Documents
4. FDA Says It Hasnt Decided Whether to Pull Diabetes Drug Avandia Off the Market
5. FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market
6. Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia
7. Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
8. Latest Study on Diabetes Drug Avandia Finds No Heart Risks
9. FDA Reviewer Questions Results of Key Avandia Trial
10. ICU Patients at Risk for Rare Heart Rhythm Problem
11. Cook With Love This Valentines Day With Heart-Smart Recipes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avandia Heart Risks Buried by Drug Company: Report
(Date:9/1/2015)... ... September 01, 2015 , ... As ... Cross and Blue Shield of Minnesota (Blue Cross) has announced Doctor On Demand ... in San Francisco, Doctor On Demand provides immediate access to Board Certified physicians ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia ... Machine,” is still strongly maintaining her firm’s success in the hair care and ... her upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, ...
(Date:9/1/2015)... Melbourne, Florida (PRWEB) , ... ... ... Association of Professional Background Screeners (NAPBS®) has announced that Edge Information ... audit conducted by the Background Screening Credentialing Council (BSCC). , “Achieving ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding members, ... its inception more than 35 years ago. A pilot program begun by the company ... and, not just those intent on pursuing careers in these fields. The program is ...
(Date:9/1/2015)... ME (PRWEB) , ... September 01, 2015 , ... Royal ... large, new study that followed men and women for 19 years and found that, ... who did not take multivitamins. , The report is part of the September 2015 ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... Children recovering,from orthopaedic surgery feel less pain and ... a small pouch that delivers local anesthetic agents ... in adults,doctors at The Children,s Hospital of Philadelphia ... published in the November 2007 issue of the ...
... BD (Becton,Dickinson and Company) (NYSE: BDX ) announced ... Board of Directors, effective November 19, 2007. Ms. ... Executive,Officer of the Federal Reserve Bank of Boston, one ... of Governors in Washington, D.C. form,the Federal Reserve System. ...
... Del., Nov. 2 Staff and board,members of Delaware ... Lloyd, MSN, RN, for 20 years of service at ... has guided Delaware Hospice from a fledgling,grassroots organization to ... community support with quality and compassion., In 1987, ...
... lead to new treatments, researchers say , , FRIDAY, Nov. 2 ... mechanism that makes blood pressure go up or down -- ... that affects at least 50 million Americans. , A report ... is the latest in a series of studies on ...
... Rowland, Common, Romeo and Lyfe ... ... national HIV/AIDS public information campaign with the,Kaiser Family Foundation, Rap-It-Up teamed up ... THAT? RAP-IT-UP SEX,QUIZ" slated to premiere on Monday, November 5 at 7:30 ...
... full healthcare benefits for all Egyptians by,2011; schools to ... compete in the global economy, CAIRO, Egypt, Nov. ... major issues on the agenda at,the National Democratic Party ... at ways to accelerate development of a healthcare program,that ...
Cached Medicine News:Health News:Anesthesia Pouch Allows Children to Go Home Sooner After Surgery 2Health News:Anesthesia Pouch Allows Children to Go Home Sooner After Surgery 3Health News:BD Board of Directors Elects Cathy E. Minehan 2Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 2Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 3Health News:Study Describes Molecules That Control Blood Pressure 2Health News:BET Networks Special 'What U Know Bout That? Rap-It-Up Sex Quiz' HIV/AIDS To Premiere On Monday, November 5 At 7:30 P.M. ET/PT 2Health News:BET Networks Special 'What U Know Bout That? Rap-It-Up Sex Quiz' HIV/AIDS To Premiere On Monday, November 5 At 7:30 P.M. ET/PT 3Health News:BET Networks Special 'What U Know Bout That? Rap-It-Up Sex Quiz' HIV/AIDS To Premiere On Monday, November 5 At 7:30 P.M. ET/PT 4Health News:Social Justice Issues Take Main Stage at Egypt's National Democratic Party Convention 2
(Date:9/1/2015)... The global Bioinformatics ... sectors, products & services and application. And the rising ... increasing demand of advanced drugs for the diagnosis ... growth for bioinformatics market. The implementation of information ... as bioinformatics. Decreasing cost of DNA sequencing, continuous ...
(Date:9/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/r8v22b/regulatory ) has announced the ... (London, UK - September 24-25, 2015)" conference to ... provides an introduction to Pharmaceutical Regulatory Affairs and the ... for those working in a support staff role. ... regulatory procedures required to register products in ...
(Date:9/1/2015)... , September 1, 2015 - ... GARFIELD-AF R egistry data presented at ... on the evolution of manag ... -   The first-ever two-year outcomes from ... ESC Congress 2015 expose that all-cause death was the most frequent major event ...
Breaking Medicine Technology:Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
Used to negotiate tortuous vessels....
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
Medicine Products: